Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisuke Nakata

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Japanese Economic Review (Oxford, England)|September 27, 2021
COVID-19 and output in JapanDaisuke Fujii, Taisuke Nakata
Japanese Economic Review (Oxford, England)|October 19, 2021
Correction to: COVID‑19 and output in JapanDaisuke Fujii, Taisuke Nakata
Plos One|April 9, 2024
Heterogeneous risk attitudes and waves of infectionDaisuke Fujii, Taisuke Nakata, Takeshi Ojima
Scientific Reports|July 19, 2024
Three years of COVID-19-related school restrictions and mental health of children and adolescents in JapanReo Takaku, Naohisa Shobako, Taisuke Nakata
Mathematical Biosciences and Engineering : MBE|August 23, 2024
Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in JapanToshikazu Kuniya, Taisuke Nakata, Daisuke Fujii
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Steroid sulfatase inhibitor]Taisuke Nakata, Hiroyuki Ishida, Yukimasa Shiotsu
Breast Cancer (Tokyo, Japan)|June 7, 2006
New development in intracrinology of breast carcinomaHironobu Sasano, Takashi Suzuki, Taisuke Nakata, et al.
Scientific Reports|May 20, 2026
COVID-19 and suicide in Japan from March 2020 to February 2023Quentin Batista, Daisuke Fujii, Taisuke Nakata, et al.
Frontiers in Public Health|July 10, 2026
COVID-19 symptom duration: evidence from a survey of infected workers in TokyoAsako Chiba, Taisuke Nakata, Naohisa Shobako, et al.
Scientific Reports|July 23, 2024
COVID-19 risk perceptions in Japan: a cross-sectional studyAsako Chiba, Taisuke Nakata, Thuy Linh Nguyen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Japanese Economic Review (Oxford, England)|September 27, 2021
COVID-19 and output in JapanDaisuke Fujii, Taisuke Nakata
Japanese Economic Review (Oxford, England)|October 19, 2021
Correction to: COVID‑19 and output in JapanDaisuke Fujii, Taisuke Nakata
Plos One|April 9, 2024
Heterogeneous risk attitudes and waves of infectionDaisuke Fujii, Taisuke Nakata, Takeshi Ojima
Scientific Reports|July 19, 2024
Three years of COVID-19-related school restrictions and mental health of children and adolescents in JapanReo Takaku, Naohisa Shobako, Taisuke Nakata
Mathematical Biosciences and Engineering : MBE|August 23, 2024
Optimal vaccine allocation strategy: Theory and application to the early stage of COVID-19 in JapanToshikazu Kuniya, Taisuke Nakata, Daisuke Fujii
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 12, 2010
[Steroid sulfatase inhibitor]Taisuke Nakata, Hiroyuki Ishida, Yukimasa Shiotsu
Breast Cancer (Tokyo, Japan)|June 7, 2006
New development in intracrinology of breast carcinomaHironobu Sasano, Takashi Suzuki, Taisuke Nakata, et al.
Scientific Reports|May 20, 2026
COVID-19 and suicide in Japan from March 2020 to February 2023Quentin Batista, Daisuke Fujii, Taisuke Nakata, et al.
Frontiers in Public Health|July 10, 2026
COVID-19 symptom duration: evidence from a survey of infected workers in TokyoAsako Chiba, Taisuke Nakata, Naohisa Shobako, et al.
Scientific Reports|July 23, 2024
COVID-19 risk perceptions in Japan: a cross-sectional studyAsako Chiba, Taisuke Nakata, Thuy Linh Nguyen, et al.
Pageof 3